Results

Total Results: 1,544 records

Showing results for "drug".

381. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - Waltham, MA Food & Drug Administration Andrew D. Mosholder, M.D., M.P.H. … Food and Drug Administration. Drug Safety and Risk Management Advisory Committee Meeting. … Pharmacoepidemiol Drug Saf 2010 Jun;19(6):563-72. 21. Miettinen OS. … Pharmacoepidemiol Drug Saf 2006 May;15(5):291-303. 25. … Drug Saf 2009;32(11):1089-96.

382. Insomnia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
     December 01, 2015 - Most included drug trials were 4 to 6 weeks in duration. … Older trials and drug trials were less likely to measure and report global outcomes. … Eligible drug trials rarely lasted longer than 6 weeks. … Drug Class Review: Newer Drugs for Insomnia: Final Report Update 2 [Internet]. … Drug Class Reviews.

383. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
     May 29, 2025 - This" expert"also"suggested"that"we"consider"the"differences"within"drug"classes"(i.e." … $unspecified$“ACEIs”$ •$ Include$ACEI$+$drug$X$vs.$ARB$+$drug$X$(e.g.,$losartan$+$HCTZ$vs. … $enalapril$+$ HCTZ)$ •$ Exclude$ACEI$+$drug$X$vs. … $ARB$+$drug$Y$(e.g.,$enalapril$+$manidipine$vs.$ irbesartan$+$HCTZ)$ •$ Exclude$if$ACEI$,$ARB,$or$ … '' $ Drug$therapy$often$fails$to$control$hypertension.

384. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Food and Drug Administration (FDA) for multilevel cervical disc replacement. … Food and Drug Administration for two-level Mobi-C cervical disc. [internet]. … Food and Drug Administration (FDA); 2009 May 4 [accessed 2013 May 7]. [2 p]. … Food and Drug Administration (FDA). … Food and Drug Administration (FDA).

385. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Table should note that this drug is not FDA approved. … drug-drug interaction with clopidogrel and certain PPIs. … On October 27, 2010, the FDA issued a statement to We did not assess drug interaction independently … Furthermore, clinical drug-drug interaction studies in mainly CYP2C19 extensive and intermediate metabolizers … Peer Reviewer #3 Discussion The data on drug therapy are rather clear cut pertaining to esophagitis

386. Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/eccs-2006/white-paper

387. Point-Of-Care Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
     April 01, 2014 - We typically did not review evidence summaries on specific interventions, such as specific drugs or drug … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … Donahue KE, et al., Drug Therapy for Rheumatoid Arthritis in Adults: An Update.

388. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - Weak opioids; investigators prescribed most suitable drug and daily dose, and would switch to another … the trial did not indicate clear differences between treatments for pain, functioning, depression, or drug … Excluded patients with history of psychosis Substance use: Excluded patients with history of illicit drug … stroke, and intracranial hemorrhage), major depression, cancer, and those without previous related drug … ; OAT = opioid agonist therapy; OR = odds ratio; OUD = opioid use disorder; PDMP = prescription drug

389. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
     June 28, 2013 - good as “strict” rate control is not completely proven, but surly the default should be less toxic drug … In looking at studies that reported an outcome of recurrence of AF or adverse drug event, once again … TEP #4 ES (Results) One of the bullets for KQ 4 (drug pretreatment) seems inconsistent with the … TEP #4 ES (Results) ES Table D: In some cases OR’s are presented but others not (Drug enhancement of … TEP #2 Results Page 47, line 31: “and” should be changed to an [in the phrase “and antiarrythmic drug

390. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Food and Drug Administration (FDA)-approved labeling for propofol states that the drug “should be administered … Food and Drug Administration (FDA); 2009 May 28. 32 p. … Food and Drug Administration (FDA). 510(k) summary for Raisin personal monitor [K093976]. … Food and Drug Administration (FDA); 2010 Mar 25 [accessed 2010 Dec 27]. [10 p]. … Food and Drug Administration (FDA); 2012 May 14. 10 p.

391. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Food and Drug Administration in July 2013 as a clinician evaluation–adjunct assessment tool. … Food and Drug Administration (FDA). Oxytocin. [internet]. Silver Spring (MD): U.S. … Food and Drug Administration (FDA) [accessed 2013 Nov 18]. [2 p]. … Food and Drug Administration (FDA). Syntocinon. [internet]. Silver Spring (MD): U.S. … Food and Drug Administration (FDA); [accessed 2013 Nov 18]. [2 p].

392. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - Additional searches included statistical and medical reviews of drug applications posted by the U.S. … Food and Drug Administration (FDA), information packages submitted by the pharmaceutical companies marketing … Statin plus another hypolipidemic drug combination therapy was compared with statin monotherapy. … statins and doses comparing any dose and subtype of statin plus any dose of a nonstatin lipid-lowering drug … Food and Drug Administration approved a statin drug, pitavastatin, which was excluded in this review

393. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
     June 01, 2010 - delivery and long-term drug safety remain.13 FDA Approved Treatments No treatments approved by … the Food and Drug Administration (FDA) for the prevention of preterm birth are currently on the market … Adeza submitted a new drug application to the FDA in May 2006 for Gestiva®, which is indicated for the … • Key Questions 4 and 6 will address issues of accessibility and drug formulation. … , availability of drug in formularies, and Medicaid and private payer coverage?

394. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - No COI) Community 18–50 y; BMI 20–30kg/m2; good general health. physical or mental disease; surgery; drug … abuse; severe allergy or abnormal drug reaction; smoking; pregnant, lactating or planning pregnancy; … experimental drug within 4 wk before, former participation in a pre- probiotic or laxative trial within … ; .intake of an experimental drug; former participation in prebiotic, probiotic or laxative (3 mo); … use; antibiotics use, antidiarrheal drug use; laxative use; pre/pro-biotics use 2 wk 2 wk 2/ Day 14

395. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - kg/m2, without physical or mental health issues pregnancy, gastrointestinal complaints, recreational drug … abuse; severe allergy or abnormal drug reaction; smoking; pregnant, lactating or planning pregnancy; … experimental drug within 4 wk before, former participation in a pre- probiotic or laxative trial within … ; .intake of an experimental drug; former participation in prebiotic, probiotic or laxative (3 mo); … use; antibiotics use, antidiarrheal drug use; laxative use; pre/pro-biotics use 2 wk 2 wk 2/ Day 14

396. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
     May 29, 2025 - provider, not investigator Yes: • Blinding methods appear adequate (e.g., double-dummy technique for drug … with no additional details) Yes: • Blinding methods appear adequate (e.g., double-dummy technique for drug … with no additional details) Yes: • Blinding methods appear adequate (e.g., double-dummy technique for drug

397. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - DMTs currently approved by the Food and Drug Administration (FDA) for RRMS include interferon (IFN) … Women considering pregnancy face special considerations for drug holidays. … • What drug should I start with? … • When should I switch to a new drug and what should that drug be? … What drug do I start with? If/when should I switch to what drug? When should I discontinue?

398. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - medications for medications in the use of high-risk medications in the elderly and potentially harmful drug

399. Executive Summary_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
     May 01, 2023 - postpartum hospital stay (reported in only one study), and adverse events (due to sparseness of data per drug … that addressed quality of life, psychosocial distress, reduction in health disparities, or adverse drug … ambulation), maternal-neonatal bonding, psychosocial distress, reduction in health disparities, or adverse drug

400. uterine-fibroids-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
     March 01, 2016 - Food and Drug Administration (FDA) for treatment of fibroid symptoms, though several medications are … US Department of Health and Human Services, Food and Drug Administration; Issued: Nov 24, 2014. … Medications for uterine fibroid treatment Drug  Category   Drug  Name   Brand/Other  Names   Labeled … City     USA   Source: www.effectivehealthcare.ahrq.gov Published online: March 1, 2016 20   Drug …  therapy[mh]  OR  drug  therapy[sh]  OR  complementary   therapies[mh]  OR  Treatment  outcome[mh]